{"id":558963,"date":"2026-08-04T18:46:12","date_gmt":"2026-08-04T18:46:12","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/558963\/"},"modified":"2026-08-04T18:46:12","modified_gmt":"2026-08-04T18:46:12","slug":"partner-3-7-year-tavr-vs-savr-outcomes-in-low-risk-patients","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/558963\/","title":{"rendered":"PARTNER 3: 7-Year TAVR vs. SAVR Outcomes in Low-Risk Patients"},"content":{"rendered":"<p>Both TAVR and SAVR were associated with a sustained, substantial improvement in patient-reported health status among patients with severe aortic stenosis (AS) considered at low risk, according to the <a href=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2026.06.022\" target=\"_blank\" rel=\"nofollow noopener\">seven-year outcomes of the PARTNER 3 trial<\/a> published July 29 in JACC. TAVR was associated with earlier recovery than SAVR.<\/p>\n<p>The PARTNER 3 trial, conducted across 71 international centers, randomized 943 patients (mean age, 74 years; 31% women) with severe AS and low surgical risk (mean STS-PROM, 1.9%) to either TAVR with a balloon-expandable valve (n=494) or SAVR (n=449). Mean baseline KCCQ-OS score was 70.9 among all patients.<\/p>\n<p>Results at seven years showed that 66% of TAVR patients vs. 67% of SAVR patients were alive with favorable outcomes (p=0.695), defined as a KCCQ-OS score \u226560 and no decrease \u226510 points. Additionally, 59% of TAVR patients vs. 62% of SAVR patients were alive with excellent outcomes (p=0.404), defined as a KCCQ-OS score \u226575 and no decrease \u226510 points.<\/p>\n<p>KCCQ-OS scores were substantially higher among TAVR patients at one-month post-procedure, with 93% of TAVR patients reporting a meaningful health status improvement across all KCCQ domains compared with 63% of SAVR patients (mean treatment difference, +16.2 points). While a small but statistically significant health-status advantage for TAVR persisted from six months through two years (mean difference, +1.9 points), there were no significant differences between treatment groups by the third year.<\/p>\n<p align=\"center\"><img decoding=\"async\" class=\"w_70:md w_100\" src=\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/08\/Brener-Central-Illustration.jpg\" alt=\"JACC Central Illustration depicting the results of the PARTNER 3 health status substudy on long-term outcomes for SAVR vs. TAVR\"\/><\/p>\n<p>Among subgroups, investigators Michael Brener, MD, et al., noted there was significant potential long-term benefit of TAVR over SAVR in patients with a lower LVEF (p=0.027) and borderline possible long-term benefit of SAVR over TAVR in older patients (p=0.053).<\/p>\n<p>Adding that this was the longest follow-up study comparing TAVR with SAVR, Brener and colleagues write that in total, &#8220;These findings highlight both the early advantage of a less-invasive approach and the sustained durability of symptom relief with either treatment strategy, providing a more complete understanding of the patient experience after valve replacement that can inform shared decision-making.&#8221;<\/p>\n<p>&#13;<br \/>\n        Keywords: &#13;<br \/>\n        Transcatheter Aortic Valve Replacement, Heart Valve Diseases, Aortic Valve Stenosis, Heart Valve Prosthesis, Quality of Life&#13;\n     <\/p>\n","protected":false},"excerpt":{"rendered":"Both TAVR and SAVR were associated with a sustained, substantial improvement in patient-reported health status among patients with&hellip;\n","protected":false},"author":2,"featured_media":56393,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[134,111,139,69],"class_list":["post-558963","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/558963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=558963"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/558963\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/56393"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=558963"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=558963"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=558963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}